Healthcare investments require more than reviewing revenue, growth projections, and financial statements. Investors also need to understand how a healthcare business manages its regulatory responsibilities.
Compliance-Driven Due Diligence helps investors identify potential compliance risks before completing an investment or acquisition. It examines the practices behind the financial results and provides a clearer view of potential exposure.
A healthcare company can show strong financial performance while still having issues with billing, ownership, referrals, licensing, privacy, or internal controls. Finding those issues early gives investors more time to assess the risks and decide how to address them.
Why Compliance Matters in Healthcare Investments
Healthcare organizations operate under a wide range of federal and state requirements. Their responsibilities can involve Medicare, Medicaid, professional licensing, patient privacy, billing, physician relationships, and other regulatory areas.
A compliance problem can affect much more than a company’s reputation. It may lead to repayment obligations, penalties, investigations, operational disruption, or additional costs after an acquisition.
The HHS Office of Inspector General recommends healthcare compliance programs that include written policies, training, communication, auditing, monitoring, and corrective action. These guidelines provide a useful framework for assessing compliance practices.
For investors, this means compliance should be reviewed alongside financial and operational performance.
What Should Investors Review?
The review should begin with the target’s business model. A physician practice will have different risks from a nursing facility, laboratory, pharmacy, or healthcare management company.
- Billing and coding should receive particular attention because revenue depends on accurate claims and supporting documentation. Investors should review billing controls, coding practices, payer relationships, and unusual reimbursement patterns that could indicate further risks.
- Ownership is another important area because healthcare businesses can involve management companies, physicians, property owners, investors, and other service providers. Investors should understand these relationships and determine who actually owns, manages, or controls the business.
- CMS ownership requirements deserve attention, particularly for nursing facilities. CMS requires skilled nursing facilities to disclose additional information about owners, managers, financial controllers, and certain parties providing services or having financial relationships with the facility.
- Referral arrangements should be reviewed carefully because financial relationships involving physicians and referral sources can create concerns under federal healthcare laws. Investors should examine compensation arrangements, management agreements, marketing relationships, and other transactions connected with referrals.
- Licensing and credentialing should be confirmed before closing because healthcare services often depend on valid facility licenses and professional credentials. Investors should also determine whether the target has reliable processes for monitoring renewals and maintaining required approvals.
- Patient privacy and data security should form part of the review because healthcare organizations handle sensitive patient information. Investors should understand how the target protects information, controls access, responds to incidents, and trains employees.
Billing Compliance Can Affect Investment Value
Billing deserves particular attention because healthcare revenue often depends on government and commercial insurance payments.
Investors should determine whether reported revenue is supported by appropriate documentation and whether billing practices follow applicable requirements. Repeated coding problems or weak documentation can create financial and regulatory exposure.
The review should also consider whether the target has identified previous billing problems and whether corrective measures were implemented.
This distinction matters because a past compliance problem may be manageable when the organization has already identified the cause and corrected the process.
A recurring problem can present a different level of risk because it may indicate weaknesses in management oversight or internal controls.
Ownership Transparency Is Becoming More Important
Healthcare investment structures can involve several connected entities. The company being purchased may not provide the complete picture of the people and organizations involved in its operations.
CMS has increased transparency around nursing facility ownership and related parties. Its requirements cover certain owners, managers, financial controllers, property relationships, and service providers.
CMS also requires certain information about whether an owning or managing entity qualifies as a private equity company or real estate investment trust for Medicare enrollment purposes.
For investors, this makes ownership mapping an important part of due diligence. The review should identify direct and indirect relationships before the transaction moves forward.
Referral Arrangements Need Careful Attention
Healthcare referral relationships can create significant compliance concerns when financial arrangements are involved.
The federal Anti-Kickback Statute prohibits certain remuneration intended to induce or reward referrals involving items or services payable by federal healthcare programs.
Investors should therefore review physician compensation, marketing arrangements, management agreements, and other financial relationships connected with referrals.
The written contract should not be the only focus. Investors should also understand how the arrangement operates in practice.
Recent enforcement activity shows why this matters. In September 2025, the Department of Justice announced that a laboratory CEO, physicians, and marketers agreed to pay more than $6 million to resolve allegations involving illegal payments for laboratory referrals.
For investors, the case reinforces the importance of examining both contractual arrangements and actual business practices.
A Compliance Program Should Work in Practice
A healthcare organization may have detailed compliance policies, but policies alone do not demonstrate effective compliance.
Investors should determine whether employees receive training and whether management monitors compliance risks. They should also review how the organization handles complaints, investigations, audits, and corrective actions.
The OIG identifies seven basic elements for healthcare compliance programs, including written policies, compliance responsibility, training, communication, auditing, corrective action, and disciplinary standards.
The key question is simple: Does the compliance program actually work?
A company that regularly identifies and corrects problems may have a different risk profile from one that rarely monitors its compliance activities.
Case Study: Nursing Facility Ownership
Nursing facility ownership provides a useful example of why investors need to look beyond the immediate corporate structure.
CMS’s ownership disclosure requirements require skilled nursing facilities and nursing facilities to provide information about certain owners and other parties involved in their operations.
The disclosures can cover people or organizations with financial control, property relationships, administrative responsibilities, clinical consulting roles, accounting responsibilities, or cash management functions.
For investors, this demonstrates why an ownership review should extend beyond the name of the company being acquired. Understanding the wider structure can reveal relationships that may require additional compliance review.
Case Study: Medicare Advantage Compliance
Medicare Advantage is another area where compliance review can provide important investment insights.
The OIG issued its Medicare Advantage Industry Segment-Specific Compliance Program Guidance in February 2026. The guidance identifies compliance risk areas and recommendations for organizations operating in the Medicare Advantage sector.
For investors, the guidance provides a useful reference when assessing Medicare Advantage-related businesses.
The review should consider how the organization identifies compliance risks, monitors its operations, trains employees, and responds when problems are identified.
What Happens When a Compliance Problem Is Found?
Finding a compliance issue does not automatically mean that an investment should be abandoned.
The first step is to understand what happened and determine how widely the issue affects the business. Investors should then assess the potential financial, operational, regulatory, and reputational impact.
Some issues may be resolved before closing. Others may require additional transaction protections, changes to deal terms, or a formal remediation plan after closing.
More serious concerns may require specialized healthcare legal or compliance advice before the transaction proceeds.
The important point is to identify the issue before ownership changes hands.
How Compliance-Driven Due Diligence Supports Better Decisions
Compliance-Driven Due Diligence gives investors information that financial statements alone cannot provide.
It can show whether revenue is supported by appropriate billing practices, whether ownership relationships are transparent, and whether compliance controls operate effectively.
It can also identify unresolved investigations, licensing concerns, referral risks, privacy weaknesses, and gaps in internal oversight.
These findings can influence valuation, transaction terms, remediation plans, and post-acquisition priorities.
The value of the process is therefore not limited to finding violations. It helps investors understand the overall risk profile of the business.
7 Key Insights for Healthcare Investors
1. Start Early
Beginning the compliance review early gives investors more time to investigate significant concerns and address issues before closing.
2. Understand the Revenue
Review billing, coding, documentation, and payer relationships to determine whether reported healthcare revenue is properly supported.
3. Map the Relationships
Examine ownership, management, physician, referral, property, and service relationships to identify potential compliance concerns.
4. Check Regulatory Requirements
Confirm licenses, certifications, government program participation, investigations, and other requirements relevant to the target’s activities.
5. Test the Compliance Program
Look beyond written policies and determine whether training, monitoring, reporting, auditing, and corrective action operate effectively.
6. Investigate Open Issues
Review audits, complaints, investigations, settlements, regulatory findings, and previous compliance problems before completing the transaction.
7. Plan for Remediation
When problems are identified, determine their scope and decide whether corrective action should occur before closing or after the investment.
Key Takeaways
Healthcare investors need to understand more than the financial performance of a potential investment. They also need a clear view of how the business manages compliance risks.
Compliance-Driven Due Diligence provides a practical way to identify those risks before they become costly post-closing problems.
Billing, ownership, referral arrangements, licensing, privacy, compliance programs, and regulatory matters should all receive appropriate attention.
Investors should also compare written policies with actual business practices. A strong compliance program should be active, monitored, and supported by corrective action.
The next step is to identify the target’s highest-risk areas and review the supporting records carefully. Significant findings should then be assessed with qualified healthcare compliance and legal professionals.
A focused compliance review can help investors make better-informed decisions, negotiate from a stronger position, and enter a transaction with a clearer understanding of potential risks.
